Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Placental choriocarcinoma complicated with fetomaternal hemorrhage syndrome: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trial.

European journal of heart failure·2026
Same author

[Clear cell papillary cystadenoma of the ovary: a clinicopathological analysis of two cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

[Correlation analysis between myopia growth and physical development parameters of school-age children in Shihezi area, Xinjiang Uyghur Autonomous Region].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2024
Same author

[Plumbagin protect against sepsis-induced myocardial injury in mice by inhibiting the JAK2/STAT3 signaling pathway to reduce cardiomyocyte pyroptosis].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Same author

VESCL: an open source 2D vessel contouring library.

International journal of computer assisted radiology and surgery·2024

相关实验视频

Updated: Jun 15, 2026

Skeletal Muscle Neurovascular Coupling, Oxidative Capacity, and Microvascular Function with 'One Stop Shop' Near-infrared Spectroscopy
09:04

Skeletal Muscle Neurovascular Coupling, Oxidative Capacity, and Microvascular Function with 'One Stop Shop' Near-infrared Spectroscopy

Published on: February 20, 2018

循环核酸化酶5型活性在运动期间限制了血液流向过心肌的血流.

J H Traverse1, Y J Chen, R Du

  • 1Department of Medicine, Division of Cardiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Circulation
|January 11, 2000
PubMed
概括

作为PDE5抑制剂的西尔德纳菲尔,通过扩大冠状动脉血管,在运动期间增加了对缺血性心脏的血液流动. 这一发现对于了解其对冠状动脉狭窄和心肌 perfusion 的影响至关重要.

科学领域:

  • 心血管生理学心血管生理学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 氧化 (NO) 通过cGMP调节血管扩张,由固酶 (PDEs) 调节.
  • 作为PDE5抑制剂的西尔德纳菲尔可以放松冠状动脉.
  • 这项研究调查了西尔德纳菲尔在正常心脏和缺血心脏中炼期间对冠状动脉血流的影响.

研究的目的:

  • 为了评估西尔代纳菲尔对冠状动脉血流和血液动力学的影响.
  • 为了评估在运动期间正常和缺血条件下西尔代纳菲尔的疗效.

主要方法:

  • 使用慢性仪器犬. 使用慢性仪器犬.
  • 用于西尔代纳菲尔 (2毫克/公斤PO).
  • 在休息和跑步机运动期间测量冠状动脉血流和血液动力学,有和没有诱导的冠状动脉狭窄.

主要成果:

  • 在正常的狗中,西尔德纳菲尔略微增加了静止冠状动脉血流.
  • 在狭窄的情况下炼显著降低了冠状动脉血流.
  • 在炼期间,西尔德纳菲尔增加了缺血区域的血液流动.

结论:

  • 用西尔代纳菲尔抑制PDE5扩大冠状动脉抵抗血管.

更多相关视频

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

相关实验视频

Last Updated: Jun 15, 2026

Skeletal Muscle Neurovascular Coupling, Oxidative Capacity, and Microvascular Function with 'One Stop Shop' Near-infrared Spectroscopy
09:04

Skeletal Muscle Neurovascular Coupling, Oxidative Capacity, and Microvascular Function with 'One Stop Shop' Near-infrared Spectroscopy

Published on: February 20, 2018

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

  • 在有狭窄的情况下,在运动期间,西尔德纳菲尔增强了对缺血性心肌的血液流动.